Vertex Pharmaceuticals Inc
F:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
F:VX1
|
US |
|
C
|
Cofle SpA
MIL:CFL
|
IT |
|
H
|
Hochtief AG
DUS:HOT
|
DE |
|
D
|
Dr Ing hc F Porsche AG
OTC:DRPRF
|
DE |
|
C
|
CECO Environmental Corp
NASDAQ:CECO
|
US |
|
eBay Inc
NASDAQ:EBAY
|
US |
|
IAR Systems Group AB
F:NC91
|
SE |
|
Telkom Indonesia (Persero) Tbk PT
OTC:TLKMF
|
ID |
|
Christian Dior SE
OTC:CHDRF
|
FR |
|
ING Groep NV
AEX:INGA
|
NL |
|
C
|
Campbell Soup Co
F:CSC
|
US |
|
Burkhalter Holding AG
SIX:BRKN
|
CH |
|
Bangkok Bank PCL
SET:BBL
|
TH |
|
E
|
Exelon Corp
BMV:EXC
|
US |
|
Italian Wine Brands S.P.A.
F:MR3
|
IT |
|
B
|
Baker Hughes Co
NASDAQ:BKR
|
US |
|
W
|
Walmart Inc
BMV:WMT
|
US |
|
H
|
Hess Corp
SWB:AHC
|
US |
|
N
|
Novatek PAO
LSE:NVTK
|
RU |
|
Pidilite Industries Ltd
NSE:PIDILITIND
|
IN |
|
Denison Mines Corp
TSX:DML
|
CA |
|
A
|
Amphenol Corp
F:XPH
|
US |
Bankruptcy Probability
Vertex Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vertex Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
280.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vertex Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vertex Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
